Feline Coronavirus in Multicat Environments

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 6, 2011, Pages 1133-1169

  Drechsler, Yvonne ^a   Alcaraz, Ana ^a   Bossong, Frank J ^a   Collisson, Ellen W ^a   Diniz, Pedro Paulo V P ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cats; Control; Diagnosis; Feline infectious peritonitis; Outbreak; Prevention

Indexed keywords

ALPHA INTERFERON; CORONA VIRUS VACCINE; DEXAMETHASONE; HYPOCHLORITE SODIUM; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; OXIDIZING AGENT; PHENOL DERIVATIVE; POLYPRENYL; PREDNISONE; QUATERNARY AMMONIUM DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG; VIDARABINE; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS RNA; VIRUS VACCINE;

ANIMAL CARE; ANTIGEN ANTIBODY REACTION; BIOCHEMISTRY; BIOTYPE; BLOOD CELL COUNT; CAT DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; CORONAVIRUS; CORONAVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISINFECTION; ENVIRONMENTAL STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HEALTH EDUCATION; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; MIXED INFECTION; NONHUMAN; PATHOLOGICAL ANATOMY; PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; RNA ANALYSIS; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; VETERINARY MEDICINE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS GENOME; VIRUS PARTICLE; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; CAT DISEASES; CATS; CORONAVIRUS INFECTIONS; CORONAVIRUS, FELINE; DISEASE OUTBREAKS; FELINE INFECTIOUS PERITONITIS; INCIDENCE; POPULATION DENSITY; PREVALENCE; PROGNOSIS; VACCINATION; VIRUS SHEDDING;

EID: 82755189147     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2011.08.004     Document Type: Review

References (193)

1. Rohrbach B.W., Legendre A.M., Baldwin C.A., et al. Epidemiology of feline infectious peritonitis among cats examined at veterinary medical teaching hospitals. J Am Vet Med Assoc 2001, 218(7):1111-1115.
2. Cave T.A., Thompson H., Reid S.W., et al. Kitten mortality in the United Kingdom: a retrospective analysis of 274 histopathological examinations (1986 to 2000). Vet Rec 2002, 151(17):497-501.
3. Decaro N., Buonavoglia C. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol 2008, 132(3-4):221-234.
4. Garwes D.J. Transmissible gastroenteritis. Vet Rec 1988, 122(19):462-463.
5. Perlman S., Dandekar A.A. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 2005, 5(12):917-927.
6. Sharpee R.L., Mebus C.A., Bass E.P. Characterization of a calf diarrheal coronavirus. Am J Vet Res 1976, 37(9):1031-1041.
7. Ward J.M. Morphogenesis of a virus in cats with experimental feline infectious peritonitis. Virology 1970, 41(1):191-194.
8. Pedersen N.C., Boyle J.F., Floyd K. Infection studies in kittens, using feline infectious peritonitis virus propagated in cell culture. Am J Vet Res 1981, 42(3):363-367.
9. Collisson E.W., Pei J., Dzielawa J., et al. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry. Dev Comp Immunol 2000, 24(2-3):187-200.
10. Masters P.S. The molecular biology of coronaviruses. Adv Virus Res 2006, 66:193-292.
11. Anderson L.J., Tong S. Update on SARS research and other possibly zoonotic coronaviruses. Int J Antimicrob Agents 2010, 36(Suppl 1):S21-S25.
12. Gorbalenya A.E., Snijder E.J., Spaan W.J. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol 2004, 78(15):7863-7866.
13. Lai M.M.C., Perlman S., Anderson L.J. Coronaviridae. Fields virology 2007, vol 1:1305-1335. Lippincott William & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
14. Pedersen N.C., Ward J., Mengeling W.L. Antigenic relationship of the feline infections peritonitis virus to coronaviruses of other species. Arch Virol 1978, 58(1):45-53.
15. Wise A.G., Kiupel M., Maes R.K. Molecular characterization of a novel coronavirus associated with epizootic catarrhal enteritis (ECE) in ferrets. Virology 2006, 349(1):164-174.
16. Gonzalez J.M., Gomez-Puertas P., Cavanagh D., et al. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 2003, 148(11):2207-2235.
17. Gorbalenya A.E., Enjuanes L., Ziebuhr J., et al. Nidovirales: evolving the largest RNA virus genome. Virus Res 2006, 117(1):17-37.
18. Jacobs L., de Groot R., van der Zeijst B.A., et al. The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV). Virus Res 1987, 8(4):363-371.
19. Herrewegh A.A., Smeenk I., Horzinek M.C., et al. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 1998, 72(5):4508-4514.
20. Hohdatsu T., Nakamura M., Ishizuka Y., et al. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol 1991, 120(3-4):207-217.
21. Hohdatsu T., Okada S., Ishizuka Y., et al. The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 1992, 54(3):557-562.
22. Pedersen N.C., Evermann J.F., McKeirnan A.J., et al. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res 1984, 45(12):2580-2585.
23. Shiba N., Maeda K., Kato H., et al. Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol 2007, 124(3-4):348-352.
24. Rottier P.J. The molecular dynamics of feline coronaviruses. Vet Microbiol 1999, 69(1-2):117-125.
25. Horsburgh B.C., Brierley I., Brown T.D. Analysis of a 9.6 kb sequence from the 3' end of canine coronavirus genomic RNA. J Gen Virol 1992, 73(Pt 11):2849-2862.
26. Motokawa K., Hohdatsu T., Hashimoto H., et al. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 1996, 40(6):425-433.
27. Wesley R.D. The S gene of canine coronavirus, strain UCD-1, is more closely related to the S gene of transmissible gastroenteritis virus than to that of feline infectious peritonitis virus. Virus Res 1999, 61(2):145-152.
28. Wang L., Junker D., Collisson E.W. Evidence of natural recombination within the S1 gene of infectious bronchitis virus. Virology 1993, 192(2):710-716.
29. Wang L., Junker D., Hock L., et al. Evolutionary implications of genetic variations in the S1 gene of infectious bronchitis virus. Virus Res 1994, 34(3):327-338.
30. Wang L., Xu Y., Collisson E.W. Experimental confirmation of recombination upstream of the S1 hypervariable region of infectious bronchitis virus. Virus Res 1997, 49(2):139-145.
31. Zhang X.W., Yap Y.L., Danchin A. Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus. Arch Virol 2005, 150(1):1-20.
32. De Groot R.J., Andeweg A.C., Horzinek M.C., et al. Sequence analysis of the 3'-end of the feline coronavirus FIPV 79-1146 genome: comparison with the genome of porcine coronavirus TGEV reveals large insertions. Virology 1988, 167(2):370-376.
33. Banner L.R., Lai M.M. Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology 1991, 185(1):441-445.
34. Benetka V., Kubber-Heiss A., Kolodziejek J., et al. Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol 2004, 99(1):31-42.
35. Duarte A., Veiga I., Tavares L. Genetic diversity and phylogenetic analysis of Feline Coronavirus sequences from Portugal. Vet Microbiol 2009, 138(1-2):163-168.
36. Kummrow M., Meli M.L., Haessig M., et al. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 2005, 12(10):1209-1215.
37. Pedersen N.C., Allen C.E., Lyons L.A. Pathogenesis of feline enteric coronavirus infection. J Feline Med Surg 2008, 10(6):529-541.
38. Pedersen N.C., Black J.W., Boyle J.F., et al. Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol 1984, 173:365-380.
39. Tusell S.M., Schittone S.A., Holmes K.V. Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range. J Virol 2007, 81(3):1261-1273.
40. Tresnan D.B., Holmes K.V. Feline aminopeptidase N is a receptor for all group I coronaviruses. Adv Exp Med Biol 1998, 440:69-75.
41. Benbacer L., Kut E., Besnardeau L., et al. Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus. J Virol 1997, 71(1):734-737.
42. Kolb A.F., Hegyi A., Maile J., et al. Molecular analysis of the coronavirus-receptor function of aminopeptidase N. Adv Exp Med Biol 1998, 440:61-67.
43. Pedersen N.C. Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv Exp Med Biol 1987, 218:529-550.
44. Chang H.W., de Groot R.J., Egberink H.F., et al. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol 2010, 91(Pt 2):415-420.
45. Poland A.M., Vennema H., Foley J.E., et al. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol 1996, 34(12):3180-3184.
46. Vennema H., Poland A., Foley J., et al. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998, 243(1):150-157.
47. Pedersen N.C., Floyd K. Experimental studies with three new strains of feline infectious peritonitis virus FIPV-UCD2, FIPV-UCD3, and FIPV-UCD4. Compendium Continuing Education Practicing Veterinarians 1985, 7:1001-1011.
48. Rottier P.J., Nakamura K., Schellen P., et al. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol 2005, 79(22):14122-14130.
49. Tekes G., Hofmann-Lehmann R., Bank-Wolf B., et al. Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J Virol 2010, 84(3):1326-1333.
50. Dye C., Helps C.R., Siddell S.G. Evaluation of real-time RT-PCR for the quantification of FCoV shedding in the faeces of domestic cats. J Feline Med Surg 2008, 10(2):167-174.
51. Tekes G., Hofmann-Lehmann R., Stallkamp I., et al. Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol 2008, 82(4):1851-1859.
52. Brown M.A., Troyer J.L., Pecon-Slattery J., et al. Genetics and pathogenesis of feline infectious peritonitis virus. Emerg Infect Dis 2009, 15(9):1445-1452.
53. Herrewegh A.A.P.M., Vennema H., Horzinek M.C., et al. The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 1995, 212(2):622-631.
54. Vennema H., Heijnen L., Rottier P.J., et al. A novel glycoprotein of feline infectious peritonitis coronavirus contains a KDEL-like endoplasmic reticulum retention signal. J Virol 1992, 66(8):4951-4956.
55. Dye C., Siddell S.G. Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J Gen Virol 2005, 86(Pt 8):2249-2253.
56. Kennedy M., Boedeker N., Gibbs P., et al. Deletions in the 7a ORF of feline coronavirus associated with an epidemic of feline infectious peritonitis. Vet Microbiol 2001, 81(3):227-234.
57. Kennedy M.A., Moore E., Wilkes R.P., et al. Analysis of genetic mutations in the 7a7b open reading frame of coronavirus of cheetahs (Acinonyx jubatus). Am J Vet Res 2006, 67(4):627-632.
58. Lin C.N., Su B.L., Huang H.P., et al. Field strain feline coronaviruses with small deletions in ORF7b associated with both enteric infection and feline infectious peritonitis. J Feline Med Surg 2009, 11(6):413-419.
59. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 2009, 11(4):225-258.
60. Pedersen N.C. Serologic studies of naturally occurring feline infectious peritonitis. Am J Vet Res 1976, 37(12):1449-1453.
61. Cave T.A., Golder M.C., Simpson J., et al. Risk factors for feline coronavirus seropositivity in cats relinquished to a UK rescue charity. J Feline Med Surg 2004, 6(2):53-58.
62. Addie D.D., Dennis J.M., Toth S., et al. Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec 2000, 146(15):419-424.
63. Pedersen N.C., Sato R., Foley J.E., et al. Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus. J Feline Med Surg 2004, 6(2):83-88.
64. Luria B.J., Levy J.K., Lappin M.R., et al. Prevalence of infectious diseases in feral cats in Northern Florida. J Feline Med Surg 2004, 6(5):287-296.
65. Addie D.D., Toth S., Murray G.D., et al. Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am J Vet Res 1995, 56(4):429-434.
66. Foley J.E., Poland A., Carlson J., et al. Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc 1997, 210(9):1313-1318.
67. Addie D.D., Jarrett O. A study of naturally occurring feline coronavirus infections in kittens. Vet Rec 1992, 130(7):133-137.
68. Herrewegh A.A., Mahler M., Hedrich H.J., et al. Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 1997, 234(2):349-363.
69. Spain C.V., Scarlett J.M., Houpt K.A. Long-term risks and benefits of early-age gonadectomy in cats. J Am Vet Med Assoc 2004, 224(3):372-379.
70. Hickman M.A., Morris J.G., Rogers Q.R. Elimination of feline coronavirus infection from a large experimental specific pathogen-free cat breeding colony by serologic testing and isolation. Feline practice 1995, 23(3):96-102.
71. Pesteanu-Somogyi L.D., Radzai C., Pressler B.M. Prevalence of feline infectious peritonitis in specific cat breeds. J Feline Med Surg 2006, 8(1):1-5.
72. Tsai H.Y., Chueh L.L., Lin C.N., et al. Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan. J Feline Med Surg 2011, 13(2):74-80.
73. Norris J.M., Bosward K.L., White J.D., et al. Clinicopathological findings associated with feline infectious peritonitis in Sydney, Australia: 42 cases (1990-2002). Aust Vet J 2005, 83(11):666-673.
74. Bell E.T., Malik R., Norris J.M. The relationship between the feline coronavirus antibody titre and the age, breed, gender and health status of Australian cats. Aust Vet J 2006, 84(1-2):2-7.
75. Foley J.E., Pedersen N.C. The inheritance of susceptibility to feline infectious peritonitis in purebreed catteries. Vet Pract 1996, 24(1):14-22.
76. Hardy W.D. Immunopathology induced by the feline leukemia virus. Springer Semin Immunopathol 1982, 5(1):75-106.
77. Cotter S.M., Hardy W.D., Essex M. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat. J Am Vet Med Assoc 1975, 166(5):449-454.
78. Addie D., Belak S., Boucraut-Baralon C., et al. Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg 2009, 11(7):594-604.
79. Hurley K.F. Feline Infectious Peritonitis/Feline Enteric Coronavirus (FIP/FECV) Accessed May 8, 2001. http://www.sheltermedicine.com/shelter-health-portal/information-sheets/feline-infectious-peritonitisfeline-enteric-coronavirus-fip.
80. Potkay S., Bacher J.D., Pitts T.W. Feline infectious peritonitis in a closed breeding colony. Lab Anim Sci 1974, 24(2):279-289.
81. Mullin C.H. Feline Infectious Peritonitis. Infectious disease management in animal shelters 2009, (20):319-330.
82. Hartmann K. Feline infectious peritonitis. Vet Clin North Am Small Anim Pract 2005, 35(1):39-79. vi.
83. Kipar A., May H., Menger S., et al. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet Pathol 2005, 42(3):321-330.
84. Andrew S.E. Feline infectious peritonitis. Vet Clin North Am Small Anim Pract 2000, 30(5):987-1000.
85. Hagan W.A., Bruner D.W., Timoney J.F. Hagan and Bruner's microbiology and infectious diseases of domestic animals 1992, Comstock Publishing Assoc, Ithaca (NY).
86. Jacobse-Geels H.E., Daha M.R., Horzinek M.C. Antibody, immune complexes, and complement activity fluctuations in kittens with experimentally induced feline infectious peritonitis. Am J Vet Res 1982, 43(4):666-670.
87. Petersen N.C., Boyle J.F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 1980, 41(6):868-876.
88. Paltrinieri S., Cammarata Parodi M., Cammarata G., et al. Type IV hypersensitivity in the pathogenesis of FIPV-induced lesions. Zentralbl Veterinarmed B 1998, 45(3):151-159.
89. Wills-Karp M. Immunological mechanisms of allergic diseases. Fundamental immunology 2008, 1375-1425. Lippincott Williams & Wilkins, Philadelphia. 6th edition. W.E. Paul (Ed.).
90. Benacerraf B., Levine B.B. Immunological specificity of delayed and immediate hypersensitivity reactions. J Exp Med 1962, 115:1023-1036.
91. Takano T., Ohyama T., Kokumoto A., et al. Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Res 2011, 158(1-2):161-168.
92. Pedersen N.C., Allen C.E., Lyons L.A. Pathogenesis of feline enteric coronavirus infection. J Feline Med Surg 2008, 10(6):529-541.
93. Addie D.D., Jarrett O. Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec 2001, 148(21):649-653.
94. Addie D.D., Paltrinieri S., Pedersen N.C. Recommendations from workshops of the second international feline coronavirus/feline infectious peritonitis symposium. J Feline Med Surg 2004, 6(2):125-130.
95. Harpold L.M., Legendre A.M., Kennedy M.A., et al. Fecal shedding of feline coronavirus in adult cats and kittens in an Abyssinian cattery. J Am Vet Med Assoc 1999, 215(7):948-951.
96. Addie D.D., Schaap I.A., Nicolson L., et al. Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 2003, 84(Pt 10):2735-2744.
97. Kipar A., Meli M.L., Baptiste K.E., et al. Sites of feline coronavirus persistence in healthy cats. J Gen Virol 2010, 91(Pt 7):1698-1707.
98. Addie D.D., Jarrett O. Feline coronavirus antibodies in cats. Vet Rec 1992, 131(9):202-203.
99. Gonon V., Duquesne V., Klonjkowski B., et al. Clearance of infection in cats naturally infected with feline coronaviruses is associated with an anti-S glycoprotein antibody response. J Gen Virol 1999, 80(Pt 9):2315-2317.
100. de Groot-Mijnes J.D., van Dun J.M., van der Most R.G., et al. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J Virol 2005, 79(2):1036-1044.
101. Hohdatsu T., Yamada H., Ishizuka Y., et al. Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes. Microbiol Immunol 1993, 37(6):499-504.
102. Dewerchin H.L., Cornelissen E., Nauwynck H.J. Replication of feline coronaviruses in peripheral blood monocytes. Arch Virol 2005, 150(12):2483-2500.
103. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14(4):778-809.
104. Kawai T., Akira S. Innate immune recognition of viral infection. Nat Immunol 2006, 7(2):131-137.
105. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27(3):370-383.
106. Spiegel M., Pichlmair A., Martinez-Sobrido L., et al. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 2005, 79(4):2079-2086.
107. Versteeg G.A., Bredenbeek P.J., van den Worm S.H., et al. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 2007, 361(1):18-26.
108. Kiss I., Poland A.M., Pedersen N.C. Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8. J Feline Med Surg 2004, 6(2):89-97.
109. Takano T., Hohdatsu T., Hashida Y., et al. A "possible" involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet Microbiol 2007, 119(2-4):121-131.
110. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981, 4(2):175-189.
111. Olsen C.W., Corapi W.V., Ngichabe C.K., et al. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol 1992, 66(2):956-965.
112. Takano T., Azuma N., Hashida Y., et al. B-cell activation in cats with feline infectious peritonitis (FIP) by FIP-virus-induced B-cell differentiation/survival factors. Arch Virol 2009, 154(1):27-35.
113. Huisman W., Martina B.E., Rimmelzwaan G.F., et al. Vaccine-induced enhancement of viral infections. Vaccine 2009, 27(4):505-512.
114. Seo S.H., Wang L., Smith R., et al. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. J Virol 1997, 71(10):7889-7894.
115. Seo S.H., Collisson E.W. Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus. J Virol 1997, 71(7):5173-5177.
116. Pedersen N.C., Theilen G., Keane M.A., et al. Studies of naturally transmitted feline leukemia virus infection. Am J Vet Res 1977, 38(10):1523-1531.
117. Cotter S.M., Gilmore C.E., Rollins C. Multiple cases of feline leukemia and feline infectious peritonitis in a household. J Am Vet Med Assoc 1973, 162(12):1054-1058.
118. Haagmans B.L., Egberink H.F., Horzinek M.C. Apoptosis and T-cell depletion during feline infectious peritonitis. J Virol 1996, 70(12):8977-8983.
119. Kipar A., Kohler K., Leukert W., et al. A comparison of lymphatic tissues from cats with spontaneous feline infectious peritonitis (FIP), cats with FIP virus infection but no FIP, and cats with no infection. J Comp Pathol 2001, 125(2-3):182-191.
120. Munder M., Mallo M., Eichmann K., et al. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 1998, 187(12):2103-2108.
121. Frucht D.M., Fukao T., Bogdan C., et al. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 2001, 22(10):556-560.
122. Gessani S., Belardelli F. IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev 1998, 9(2):117-123.
123. Sen E., Chattopadhyay S., Bandopadhyay S., et al. Macrophage heterogeneity, antigen presentation, and membrane fluidity: implications in visceral Leishmaniasis. Scand J Immunol 2001, 53(2):111-120.
124. Salazar-Mather T.P., Hamilton T.A., Biron C.A. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000, 105(7):985-993.
125. Pien G.C., Satoskar A.R., Takeda K., et al. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol 2000, 165(9):4787-4791.
126. Krukowski K., Eddy J., Kosik K.L., et al. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun 2011, 25(2):239-249.
127. Giordano A., Paltrinieri S. Interferon-gamma in the serum and effusions of cats with feline coronavirus infection. Vet J 2009, 180(3):396-398.
128. Takano T., Hohdatsu T., Toda A., et al. TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology 2007, 364(1):64-72.
129. Han S., Choi H., Ko M.G., et al. Peripheral T cells become sensitive to glucocorticoid- and stress-induced apoptosis in transgenic mice overexpressing SRG3. J Immunol 2001, 167(2):805-810.
130. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009, 16(5):300-317.
131. Addie D.D. Feline coronavirus infection. Infectious diseases of the dog and cat 2006, vol 3rd:88-102. Saunders Elsevier, St. Louis. C.E. Greene (Ed.).
132. Doherty M.J. Ocular manifestations of feline infectious peritonitis. J Am Vet Med Assoc 1971, 159(4):417-424.
133. Boettcher I.C., Steinberg T., Matiasek K., et al. Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis of feline infectious peritonitis involving the central nervous system in cats. J Am Vet Med Assoc 2007, 230(2):199-205.
134. Marioni-Henry K., Vite C.H., Newton A.L., et al. Prevalence of diseases of the spinal cord of cats. J Vet Intern Med 2004, 18(6):851-858.
135. Timmann D., Cizinauskas S., Tomek A., et al. Retrospective analysis of seizures associated with feline infectious peritonitis in cats. J Feline Med Surg 2008, 10(1):9-15.
136. Foley J.E., Lapointe J.M., Koblik P., et al. Diagnostic features of clinical neurologic feline infectious peritonitis. J Vet Intern Med 1998, 12(6):415-423.
137. Diaz J.V., Poma R. Diagnosis and clinical signs of feline infectious peritonitis in the central nervous system. Can Vet J 2009, 50(10):1091-1093.
138. Sparkes A.H., Gruffydd-Jones T., Harbour D.A. Feline infectious peritonitis: a review of clinico-pathological changes in 65 cases, and critical assessment of their diagnostic value. Vet Rec 1991, 129:209-212.
139. Sparkes A.H., Gruffydd-Jones T.J., Harbour D.A. An appraisal of the value of laboratory tests in the diagnosis of feline infectious peritonitis. J Am Anim Hosp Assoc 1994, 30:345-350.
140. Norsworthy G.D. Feline infectious peritonitis. The feline patient 2006, vol 3rd:97-98. Wiley-Blackwell Publishing, Iowa. G.D. Norsworthy, M.A. Crystal, S.F. Grace (Eds.).
141. Goodson T., Randell S., Moore L. Feline infectious peritonitis. Compend Contin Educ Vet 2009, 31(10):E1-E9.
142. Paltrinieri S., Parodi M.C., Cammarata G. In vivo diagnosis of feline infectious peritonitis by comparison of protein content, cytology, and direct immunofluorescence test on peritoneal and pleural effusions. J Vet Diagn Invest 1999, 11(4):358-361.
143. Hartmann K., Binder C., Hirschberger J., et al. Comparison of different tests to diagnose feline infectious peritonitis. J Vet Intern Med 2003, 17(6):781-790.
144. Giori L., Giordano A., Giudice C., et al. Performances of different diagnostic tests for feline infectious peritonitis in challenging clinical cases. J Small Anim Pract 2011, 52(3):152-157.
145. Paltrinieri S., Giordano A., Tranquillo V., et al. Critical assessment of the diagnostic value of feline alpha1-acid glycoprotein for feline infectious peritonitis using the likelihood ratios approach. J Vet Diagn Invest 2007, 19(3):266-272.
146. Shelly S.M., Scarlett-Kranz J., Blue J.T. Protein electrophoresis on effusions from cats as a diagnostic test for feline infectious peritonitis. Journal of the American Animal Hospital Association 1988, 24:495-500.
147. Addie D.D. The Rivalta Test in diagnosis of effusive Feline Infectious Peritonitis (FIP) [Online video], Accessed May 12th, 2011. http://www.youtube.com/user/DrDianeDAddie#p/u/4/XmOk2veunqA.
148. Pedersen N. The history and interpretation of feline coronavirus serology. Feline Practice 1995, 23:46-51.
149. Richards J.R. Problems in the interpretation of feline coronavirus serology (specificity vs. sensitivity of test procedures). Feline Practice 1995, 23:52-55.
150. Soma T., Ishii H. Detection of feline coronavirus antibody, feline immunodeficiency virus antibody, and feline leukemia virus antigen in ascites from cats with effusive feline infectious peritonitis. J Vet Med Sci 2004, 66(1):89-90.
151. Kennedy M.A., Brenneman K., Millsaps R.K., et al. Correlation of genomic detection of feline coronavirus with various diagnostic assays for feline infectious peritonitis. J Vet Diagn Invest 1998, 10(1):93-97.
152. Lappin M.R., Turnwald G.H. Microbiology and infectious diseases. Small animal clinical diagnosis by laboratory methods 2004, 350-351. Elsevier, St. Louis. 4th edition. M.D. Willard, H. Tvedten (Eds.).
153. Vennema H., Rossen J.W., Wesseling J., et al. Genomic organization and expression of the 3' end of the canine and feline enteric coronaviruses. Virology 1992, 191(1):134-140.
154. Kennedy M.A., Abd-Eldaim M., Zika S.E., et al. Evaluation of antibodies against feline coronavirus 7b protein for diagnosis of feline infectious peritonitis in cats. Am J Vet Res 2008, 69(9):1179-1182.
155. Pratelli A. Comparison of serologic techniques for the detection of antibodies against feline coronaviruses. J Vet Diagn Invest 2008, 20(1):45-50.
156. Barlough J.E., Jacobson R.H., Sorresso G.P., et al. Coronavirus antibody detection in cats by computer-assisted kinetics-based enzyme-linked immunosorbent assay (KELA): field studies. Cornell Vet 1986, 76(3):227-235.
157. Shiba N., Maeda K., Kato H., et al. Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol 2007, 124(3-4):348-352.
158. Addie D. Feline Coronavirus (Feline Infectious Peritonitis) Antibody tests Accessed 4/26/2011, 2011. http://www.dr-addie.com/FCoVantibody.htm.
159. Peterson M.E., Kintzer P.P., Hurvitz A.I. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988, 2(3):150-157.
160. Breitschwerdt E.B., Abrams-Ogg A.C., Lappin M.R., et al. Molecular evidence supporting Ehrlichia canis-like infection in cats. J Vet Intern Med 2002, 16(6):642-649.
161. Gunn-Moore D.A., Gruffydd-Jones T.J., Harbour D.A. Detection of feline coronaviruses by culture and reverse transcriptase-polymerase chain reaction of blood samples from healthy cats and cats with clinical feline infectious peritonitis. Vet Microbiol 1998, 62(3):193-205.
162. Gamble D.A., Lobbiani A., Gramegna M., et al. Development of a nested PCR assay for detection of feline infectious peritonitis virus in clinical specimens. J Clin Microbiol 1997, 35(3):673-675.
163. Herrewegh A.A., de Groot R.J., Cepica A., et al. Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol 1995, 33(3):684-689.
164. Takano T., Tomiyama Y., Katoh Y., et al. Mutation of neutralizing/antibody-dependent enhancing epitope on spike protein and 7b gene of feline infectious peritonitis virus: influences of viral replication in monocytes/macrophages and virulence in cats. Virus Res 2011, 156(1-2):72-80.
165. Pedersen N., Liu H., Dodd K., et al. Significance of Coronavirus Mutants in Feces and Diseased Tissues of Cats Suffering from Feline Infectious Peritonitis. Viruses 2009, 1(2):166-184.
166. Li X., Scott F.W. Detection of feline coronaviruses in cell cultures and in fresh and fixed feline tissues using polymerase chain reaction. Vet Microbiol 1994, 42(1):65-77.
167. Simons F.A., Vennema H., Rofina J.E., et al. A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods 2005, 124(1-2):111-116.
168. Can-Sahna K., Soydal Ataseven V., Pinar D., et al. The detection of feline coronaviruses in blood samples from cats by mRNA RT-PCR. J Feline Med Surg 2007, 9(5):369-372.
169. Sharif S., Arshad S.S., Hair-Bejo M., et al. Evaluation of Feline Coronavirus Viraemia in Clinically Healthy and Ill Cats with Feline Infectious Peritonitis. Journal of Animal and Veterinary Advances 2011, 10(1):18-22.
170. Simons F.A., Vennema H., Rofina J.E., et al. A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods 2005, 124(1-2):111-116.
171. Foley J.E., Leutenegger C. A review of coronavirus infection in the central nervous system of cats and mice. J Vet Intern Med 2001, 15(5):438-444.
172. Cannon M.J., Silkstone M.A., Kipar A.M. Cutaneous lesions associated with coronavirus-induced vasculitis in a cat with feline infectious peritonitis and concurrent feline immunodeficiency virus infection. J Feline Med Surg 2005, 7(4):233-236.
173. Declercq J., De Bosschere H., Schwarzkopf I., et al. Papular cutaneous lesions in a cat associated with feline infectious peritonitis. Vet Dermatol 2008, 19(5):255-258.
174. Ritz S., Egberink H., Hartmann K. Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. J Vet Intern Med 2007, 21(6):1193-1197.
175. Ishida T., Shibanai A., Tanaka S., et al. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J Feline Med Surg 2004, 6(2):107-109.
176. Hartmann K. Feline infectious peritonitis and feline coronavirus infection. Textbook of veterinary internal medicine: diseases of the dog and the cat 2010, vol 1:940-945. Saunders Elsevier, St. Louis. S.J. Ettinger, E.C. Feldman (Eds.).
177. Legendre A.M., Bartges J.W. Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis. J Feline Med Surg 2009, 11(8):624-626.
178. Hoskins J., Taylor H., Lomax T. Independent evaluation of a modified live feline infectious peritonitis virus vaccine under experimental conditions (Louisiana experience). Feline Practice 1995, 23(3):72-73.
179. McArdle F., Bennett M., Gaskell R.M., et al. Independent evaluation of a modified live FIPV vaccine under experimental conditions (University of Liverpool experience). Feline Practice 1995, 23(3):67-71.
180. Scott F., Corapi W., Olsen C. Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline Practice 1995, 23(3):74-76.
181. Gerber J. Overview of the development of a modified live temperature-sensitive FIP virus vaccine. Feline Practice 1995, 23(3):62-66.
182. Richards J.R., Elston T.H., Ford R.B., et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. J Am Vet Med Assoc 2006, 229(9):1405-1441.
183. Day M.J., Horzinek M.C., Schultz R.D. WSAVA guidelines for the vaccination of dogs and cats. J Small Anim Pract 2010, 51(6):1-32.
184. Peterson C.A., Dvorak G., Spickler A.R. Maddie's infection control manual for animal shelters for veterinary personnel 2008, Iowa State University, Center for Food Security and Public Health, Ames (IA). 1st edition.
185. Bell E.T., Toribio J.A., White J.D., et al. Seroprevalence study of feline coronavirus in owned and feral cats in Sydney, Australia. Aust Vet J 2006, 84(3):74-81.
186. Holst B.S., Englund L., Palacios S., et al. Prevalence of antibodies against feline coronavirus and Chlamydophila felis in Swedish cats. J Feline Med Surg 2006, 8(3):207-211.
187. Pratelli A., Yesilbag K., Siniscalchi M., et al. Prevalence of feline coronavirus antibodies in cats in Bursa province, Turkey, by an enzyme-linked immunosorbent assay. J Feline Med Surg 2009, 11(10):881-884.
188. Sparkes A.H., Gruffydd-Jones T.J., Harbour D.A. Feline coronavirus antibodies in UK cats. Vet Rec 1992, 131(10):223-224.
189. Muirden A. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to an RSPCA hospital. Vet Rec 2002, 150(20):621-625.
190. Sharif S., Arshad S.S., Hair-Bejo M., et al. Prevalence of feline coronavirus in two cat populations in Malaysia. J Feline Med Surg 2009, 11(12):1031-1034.
191. Kiss I., Kecskemeti S., Tanyi J., et al. Prevalence and genetic pattern of feline coronaviruses in urban cat populations. Vet J 2000, 159(1):64-70.
192. Duthie S., Eckersall P.D., Addie D.D., et al. Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec 1997, 141(12):299-303.
193. Hirschberger J., Hartmann K., Wilhelm N., et al. [Clinical symptoms and diagnosis of feline infectious peritonitis]. Tierarztl Prax 1995, 23(1):92-99.